Related Experiment Video
Updated: May 17, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Biolistic DNA vaccination against melanoma
1Institute for Laboratory Animal Science, University Hospital of RWTH Aachen, Aachen, Germany. jsteitz@ukaachen.de
Methods in Molecular Biology (Clifton, N.J.)
|October 30, 2012
Summary
Particle-mediated gene transfer effectively induced immune responses against melanoma using tyrosinase-related protein 2 (TRP2). This approach led to tumor immunity and fur depigmentation in a mouse model, showing promise for cancer vaccines.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Melanoma is a significant form of skin cancer.
- Developing effective cancer vaccines requires robust induction of antigen-specific immune responses.
- Particle-mediated gene transfer offers a potential method for DNA vaccination.
Purpose of the Study:
- To investigate particle-mediated gene transfer for inducing immune responses against melanoma antigens.
- To evaluate the efficacy of targeting tyrosinase-related protein 2 (TRP2) in a murine B16 melanoma model.
- To establish protocols for measuring antigen-specific humoral and cellular immunity.
Main Methods:
- Utilized particle-mediated gene transfer (Helios Gene Gun) with plasmids encoding TRP2.
- Employed marker genes (β-galactosidase, EGFP) for gene delivery confirmation.
- Assessed humoral and cellular immune responses, including T-cell induction and antibody production.
Main Results:
- Successful induction of TRP2-specific T-cells and antibodies.
- Observed vitiligo-like fur depigmentation, indicating an immune response against melanocytes.
- Demonstrated tumor immunity against B16 melanoma cells.
Conclusions:
- Particle-mediated gene transfer is effective for inducing anti-melanoma immunity.
- TRP2 is a viable target antigen for melanoma immunotherapy.
- The described protocols can be adapted for other antigens and cancer types.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.